Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Hahn

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
The Analyst|March 1, 2024
Efficacy of tyrosine kinase inhibitors examined by a combination of Raman micro-spectroscopy and a deep wavelet scattering-based multivariate analysis frameworkIrina Schuler, Martin Schuler, Tatjana Frick, et al.
Cancers|June 10, 2022
New Therapy Options for Neuroendocrine Carcinoma of the Pancreas-The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In VivoMarie Buchholz, Johanna Strotmann, Britta Majchrzak-Stiller, et al.
Cancers|July 27, 2024
Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and GemcitabineMarie Buchholz, Britta Majchrzak-Stiller, Ilka Peters, et al.
Journal of Cellular and Molecular Medicine|June 30, 2023
GP-2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP-Kinase and impairs the NF-kB pathway in pancreatic cancer cellsBritta Majchrzak-Stiller, Marie Buchholz, Ilka Peters, et al.
Biophysical Journal|May 9, 2014
Automated identification of subcellular organelles by coherent anti-stokes Raman scatteringSamir F El-Mashtoly, Daniel Niedieker, Dennis Petersen, et al.
Journal of Neuro-Oncology|January 13, 2018
MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNSAlexander Baraniskin, Monika Chomiak, Guido Ahle, et al.
Scientific Reports|October 17, 2018
Raman micro-spectroscopy monitors acquired resistance to targeted cancer therapy at the cellular levelMohamad K Hammoud, Hesham K Yosef, Tatjana Lechtonen, et al.
Scientific Reports|June 16, 2021
Deficiency of myostatin protects skeletal muscle cells from ischemia reperfusion injuryChristoph Wallner, Marius Drysch, Mustafa Becerikli, et al.
Thyroid : Official Journal of the American Thyroid Association|September 8, 2016
Overexpression of Interleukin-4 in the Thyroid of Transgenic Mice Upregulates the Expression of Duox1 and the Anion Transporter PendrinZineb Eskalli, Younes Achouri, Stephan Hahn, et al.
Plos One|March 15, 2014
A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain sheddingNathalie Wojtalewicz, Elham Sadeqzadeh, Jakob V Weiß, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The Analyst|March 1, 2024
Efficacy of tyrosine kinase inhibitors examined by a combination of Raman micro-spectroscopy and a deep wavelet scattering-based multivariate analysis frameworkIrina Schuler, Martin Schuler, Tatjana Frick, et al.
Cancers|June 10, 2022
New Therapy Options for Neuroendocrine Carcinoma of the Pancreas-The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In VivoMarie Buchholz, Johanna Strotmann, Britta Majchrzak-Stiller, et al.
Cancers|July 27, 2024
Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and GemcitabineMarie Buchholz, Britta Majchrzak-Stiller, Ilka Peters, et al.
Journal of Cellular and Molecular Medicine|June 30, 2023
GP-2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP-Kinase and impairs the NF-kB pathway in pancreatic cancer cellsBritta Majchrzak-Stiller, Marie Buchholz, Ilka Peters, et al.
Biophysical Journal|May 9, 2014
Automated identification of subcellular organelles by coherent anti-stokes Raman scatteringSamir F El-Mashtoly, Daniel Niedieker, Dennis Petersen, et al.
Journal of Neuro-Oncology|January 13, 2018
MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNSAlexander Baraniskin, Monika Chomiak, Guido Ahle, et al.
Scientific Reports|October 17, 2018
Raman micro-spectroscopy monitors acquired resistance to targeted cancer therapy at the cellular levelMohamad K Hammoud, Hesham K Yosef, Tatjana Lechtonen, et al.
Scientific Reports|June 16, 2021
Deficiency of myostatin protects skeletal muscle cells from ischemia reperfusion injuryChristoph Wallner, Marius Drysch, Mustafa Becerikli, et al.
Thyroid : Official Journal of the American Thyroid Association|September 8, 2016
Overexpression of Interleukin-4 in the Thyroid of Transgenic Mice Upregulates the Expression of Duox1 and the Anion Transporter PendrinZineb Eskalli, Younes Achouri, Stephan Hahn, et al.
Plos One|March 15, 2014
A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain sheddingNathalie Wojtalewicz, Elham Sadeqzadeh, Jakob V Weiß, et al.
Pageof 4